Aging and dyslipidemia: A review of potential mechanisms

Ageing Research Reviews

Volumn 19, Issue , 2015, Pages 43-52

  Liu, Hui Hui ^a   Li, Jian Jun ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

Aging; Cardiovascular disease; Dyslipidemia; Lipoprotein metabolism

Indexed keywords

ANDROGEN; CHOLESTEROL; CLOFIBRATE; FATTY ACID; FENOFIBRATE; GEMFIBROZIL; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOFUSCIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; TESTOSTERONE; TRIACYLGLYCEROL; LIPID;

AGING; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; DISORDERS OF LIPOPROTEIN METABOLISM; DYSLIPIDEMIA; ENZYME ACTIVITY; FATTY ACID OXIDATION; GROWTH HORMONE RELEASE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERTENSION; INSULIN RESISTANCE; LIVER; NONHUMAN; OBESITY; PROTEIN EXPRESSION; REVIEW; ADULT; AGED; BLOOD; CARDIOVASCULAR DISEASES; COMPLICATION; DYSLIPIDEMIAS; FEMALE; LIPID METABOLISM; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; SEX DIFFERENCE; YOUNG ADULT;

ANIMALIA;

ADULT; AGED; AGING; CARDIOVASCULAR DISEASES; DYSLIPIDEMIAS; FEMALE; HUMANS; LIPID METABOLISM; LIPIDS; MALE; MIDDLE AGED; SEX FACTORS; YOUNG ADULT;

EID: 84918778306     PISSN: 15681637     EISSN: 18729649     Source Type: Journal    
DOI: 10.1016/j.arr.2014.12.001     Document Type: Review

References (136)

1. Abbott R.D., Garrison R.J., Wilson P.W., et al. Joint distribution of lipoprotein cholesterol classes: The Framingham Study. Arterioscler. Thromb. Vasc. Biol. 1983, 3:260-272.
2. Akiyama T.E., Nicol C.J., Fievet C., Staels B., Ward J.M., Auwerx J., Lee S.S., Gonzalez F.J., Peters J.M. Peroxisome proliferator-activated receptor-alpha regulates lipid homeostasis, but is not associated with obesity: studies with congenic mouse lines. J. Biol. Chem. 2001, 276:39088-39093.
3. Alexandersen P., Haarbo J., Christiansen C. The relationship of natural androgens to coronary heart disease in males: a review. Atherosclerosis 1996, 125:1-13.
4. Angelin B., Rudling M. Growth hormone and hepatic lipoprotein metabolism. Curr. Opin. Lipidol. 1994, 5:160-165.
5. Anonymous MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002, 360:7-22.
6. Arner P. Insulin resistance in type 2 diabetes: role of fatty acids. Diabetes Metab. Res. Rev. 2002, 18(Suppl. 2):S5-S9.
7. Arora S., Kassarjian Z., Krasinski S.D., Croffey B., Kaplan M.M., Russell R.M. Effect of age on tests of intestinal and hepatic function in healthy humans. Gastroenterology 1989, 96:1560-1565.
8. Baigent C., Blackwell L., Emberson J., Holland L.E., Reith C., Bhala N., Peto R., Barnes E.H., Keech A., Simes J., Collins R. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet 2010, 376:1670-1681.
9. Bartos V., Groh J. The effect of repeated stimulation of the pancreas on the pancreatic secretion in young and aged men. Gerontol. Clin. (Basel) 1969, 11:56-62.
10. Barzilai N., Rossetti L. Age-related changes in body composition are associated with hepatic insulin resistance in conscious rats. Am. J. Physiol. 1996, 270:E930-E936.
11. Berger J., Moller D.E. The mechanisms of action of PPARs. Annu. Rev. Med. 2002, 53:409-435.
12. Bjorntorp P. Abdominal fat distribution and the metabolic syndrome. J. Cardiovasc. Pharmacol. 1992, 20(Suppl. 8):S26-S28.
13. Boden G., Chen X., Ruiz J., White J.V., Rossetti L. Mechanisms of fatty acid-induced inhibition of glucose uptake. J. Clin. Invest. 1994, 93:2438-2446.
14. Bonadonna R.C., Groop L.C., Simonson D.C., DeFronzo R.A. Free fatty acid and glucose metabolism in human aging: evidence for operation of the Randle cycle. Am. J. Physiol. 1994, 266:E501-E509.
15. Bouillanne O., Rainfray M., Tissandier O., Nasr A., Lahlou A., Cnockaert X., Piette F. Growth hormone therapy in elderly people: an age-delaying drug?. Fundam. Clin. Pharmacol. 1996, 10:416-430.
16. Braissant O., Foufelle F., Scotto C., Dauca M., Wahli W. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology 1996, 137:354-366.
17. Campos H., Genest J.J., Blijlevens E., McNamara J.R., Jenner J.L., Ordovas J.M., Wilson P.W., Schaefer E.J. Low density lipoprotein particle size and coronary artery disease. Arterioscler. Thromb. 1992, 12:187-195.
18. Cartier A., Cote M., Lemieux I., Perusse L., Tremblay A., Bouchard C., Despres J.P. Age-related differences in inflammatory markers in men: contribution of visceral adiposity. Metabolism 2009, 58:1452-1458.
19. Cauley J.A., Gutai J.P., Kuller L.H., Dai W.S. Usefulness of sex steroid hormone levels in predicting coronary artery disease in men. Am. J. Cardiol. 1987, 60:771-777.
20. Cogger V.C., Warren A., Fraser R., Ngu M., McLean A.J., Le Couteur D.G. Hepatic sinusoidal pseudocapillarization with aging in the non-human primate. Exp. Gerontol. 2003, 38:1101-1107.
21. Corpas E., Harman S.M., Blackman M.R. Human growth hormone and human aging. Endocr. Rev. 1993, 14:20-39.
22. Danesh J., Collins R., Peto R. Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies. Circulation 2000, 102:1082-1085.
23. Desvergne B., Wahli W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr. Rev. 1999, 20:649-688.
24. Einarsson K., Nilsell K., Leijd B., Angelin B. Influence of age on secretion of cholesterol and synthesis of bile acids by the liver. N. Engl. J. Med. 1985, 313:277-282.
25. Einstein F.H., Huffman D.M., Fishman S., Jerschow E., Heo H.J., Atzmon G., Schechter C., Barzilai N., Muzumdar R.H. Aging per se increases the susceptibility to free fatty acid-induced insulin resistance. J. Gerontol. A Biol. Sci. Med. Sci. 2010, 65:800-808.
26. Elam M.B., Wilcox H.G., Solomon S.S., Heimberg M. In vivo growth hormone treatment stimulates secretion of very low density lipoprotein by the isolated perfused rat liver. Endocrinology 1992, 131:2717-2722.
27. English K.M., Mandour O., Steeds R.P., Diver M.J., Jones T.H., Channer K.S. Men with coronary artery disease have lower levels of androgens than men with normal coronary angiograms. Eur. Heart J. 2000, 21:890-894.
28. Ericsson S., Eriksson M., Vitols S., Einarsson K., Berglund L., Angelin B. Influence of age on the metabolism of plasma low density lipoproteins in healthy males. J. Clin. Invest. 1991, 87:591-596.
29. Ericsson S., Berglund L., Frostegard J., Einarsson K., Angelin B. The influence of age on low density lipoprotein metabolism: effects of cholestyramine treatment in young and old healthy male subjects. J. Intern. Med. 1997, 242:329-337.
30. Evans M.A., Triggs E.J., Cheung M., Broe G.A., Creasey H. Gastric emptying rate in the elderly: implications for drug therapy. J. Am. Geriatr. Soc. 1981, 29:201-205.
31. Fallah N., Mohammad K., Nourijelyani K., Eshraghian M.R., Seyyedsalehi S.A., Raiessi M., Rahmani M., Goodarzi H.R., Darvish S., Zeraati H., Davoodi G., Sadeghian S. Nonlinear association between serum testosterone levels and coronary artery disease in Iranian men. Eur. J. Epidemiol. 2009, 24:297-306.
32. Feldman H.A., Longcope C., Derby C.A., Johannes C.B., Araujo A.B., Coviello A.D., Bremner W.J., McKinlay J.B. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J. Clin. Endocrinol. Metab. 2002, 87:589-598.
33. Ferrara A., Barrett-Connor E., Shan J. Total, LDL, and HDL cholesterol decrease with age in older men and women. The Rancho Bernardo Study 1984-1994. Circulation 1997, 96:37-43.
34. Florentin M., Liberopoulos E.N., Wierzbicki A.S., Mikhailidis D.P. Multiple actions of high-density lipoprotein. Curr. Opin. Cardiol. 2008, 23:370-378.
35. Frohnert B.I., Jacobs D.R., Steinberger J., Moran A., Steffen L.M., Sinaiko A.R. Relation between serum free fatty acids and adiposity, insulin resistance, and cardiovascular risk factors from adolescence to adulthood. Diabetes 2013, 62:3163-3169.
36. Galman C., Matasconi M., Persson L., Parini P., Angelin B., Rudling M. Age-induced hypercholesterolemia in the rat relates to reduced elimination but not increased intestinal absorption of cholesterol. Am. J. Physiol. Endocrinol. Metab. 2007, 293:E737-E742.
37. Gao Z., Zhang X., Zuberi A., Hwang D., Quon M.J., Lefevre M., Ye J. Inhibition of insulin sensitivity by free fatty acids requires activation of multiple serine kinases in 3T3-L1 adipocytes. Mol. Endocrinol. 2004, 18:2024-2034.
38. Gillum R.F., Taylor H.L., Brozek J., Anderson J., Blackburn H. Blood lipids in young men followed 32 years. J. Chronic Dis. 1982, 35:635-641.
39. Ginsberg H.N. Insulin resistance and cardiovascular disease. J. Clin. Invest. 2000, 106:453-458.
40. Gobal F.A., Mehta J.L. Management of dyslipidemia in the elderly population. Ther. Adv. Cardiovasc. Dis. 2010, 4:375-383.
41. Gray A., Berlin J.A., McKinlay J.B., Longcope C. An examination of research design effects on the association of testosterone and male aging: results of a meta-analysis. J. Clin. Epidemiol. 1991, 44:671-684.
42. Gulick T., Cresci S., Caira T., Moore D.D., Kelly D.P. The peroxisome proliferator-activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:11012-11016.
43. Harman S.M., Tsitouras P.D. Reproductive hormones in aging men. I. Measurement of sex steroids, basal luteinizing hormone, and Leydig cell response to human chorionic gonadotropin. J. Clin. Endocrinol. Metab. 1980, 51:35-40.
44. Harman S.M., Metter E.J., Tobin J.D., Pearson J., Blackman M.R. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J. Clin. Endocrinol. Metab. 2001, 86:724-731.
45. Herbst K.L., Amory J.K., Brunzell J.D., Chansky H.A., Bremner W.J. Testosterone administration to men increases hepatic lipase activity and decreases HDL and LDL size in 3 wk. Am. J. Physiol. Endocrinol. Metab. 2003, 284:E1112-E1118.
46. Hershcopf R.J., Elahi D., Andres R., Baldwin H.L., Raizes G.S., Schocken D.D., Tobin J.D. Longitudinal changes in serum cholesterol in man: an epidemiologic search for an etiology. J. Chronic Dis. 1982, 35:101-114.
47. Hilmer S.N., Cogger V.C., Fraser R., McLean A.J., Sullivan D., Le Couteur D.G. Age-related changes in the hepatic sinusoidal endothelium impede lipoprotein transfer in the rat. Hepatology 2005, 42:1349-1354.
48. Hollander D., Dadufalza V.D. Aging-associated pancreatic exocrine insufficiency in the unanesthetized rat. Gerontology 1984, 30:218-222.
49. Horowitz M., Maddern G.J., Chatterton B.E., Collins P.J., Harding P.E., Shearman D.J. Changes in gastric emptying rates with age. Clin. Sci. (Lond.) 1984, 67:213-218.
50. Hutley L., Prins J.B. Fat as an endocrine organ: relationship to the metabolic syndrome. Am. J. Med. Sci. 2005, 330:280-289.
51. Huttunen J.K., Ehnholm C., Kekki M., Nikkila E.A. Post-heparin plasma lipoprotein lipase and hepatic lipase in normal subjects and in patients with hypertriglyceridaemia: correlations to sex, age and various parameters of triglyceride metabolism. Clin. Sci. Mol. Med. 1976, 50:249-260.
52. Iemitsu M., Miyauchi T., Maeda S., Tanabe T., Takanashi M., Irukayama-Tomobe Y., Sakai S., Ohmori H., Matsuda M., Yamaguchi I. Aging-induced decrease in the PPAR-alpha level in hearts is improved by exercise training. Am. J. Physiol. Heart Circ. Physiol. 2002, 283:H1750-H1760.
53. Irwin M., Dreyfus E., Baird S., Smith T.L., Schuckit M. Testosterone in chronic alcoholic men. Br. J. Addict. 1988, 83:949-953.
54. Issa J.S., Diament J., Forti N. Postprandial lipemia: influence of aging. Arq. Bras. Cardiol. 2005, 85:15-19.
55. Ito Y., Sorensen K.K., Bethea N.W., Svistounov D., McCuskey M.K., Smedsrod B.H., McCuskey R.S. Age-related changes in the hepatic microcirculation in mice. Exp. Gerontol. 2007, 42:789-797.
56. Jamieson H.A., Hilmer S.N., Cogger V.C., Warren A., Cheluvappa R., Abernethy D.R., Everitt A.V., Fraser R., de Cabo R., Le Couteur D.G. Caloric restriction reduces age-related pseudocapillarization of the hepatic sinusoid. Exp. Gerontol. 2007, 42:374-378.
57. Kabakci G., Yildirir A., Can I., Unsal I., Erbas B. Relationship between endogenous sex hormone levels, lipoproteins and coronary atherosclerosis in men undergoing coronary angiography. Cardiology 1999, 92:221-225.
58. Kahn B.B., Flier J.S. Obesity and insulin resistance. J. Clin. Invest. 2000, 106:473-481.
59. Koh-Banerjee P., Wang Y., Hu F.B., Spiegelman D., Willett W.C., Rimm E.B. Changes in body weight and body fat distribution as risk factors for clinical diabetes in US men. Am. J. Epidemiol. 2004, 159:1150-1159.
60. Kolovou G., Bilianou H., Marvaki A., Mikhailidis D.P. Aging men and lipids. Am. J. Men Health 2011, 5:152-165.
61. Krasinski S.D., Cohn J.S., Schaefer E.J., Russell R.M. Postprandial plasma retinyl ester response is greater in older subjects compared with younger subjects. Evidence for delayed plasma clearance of intestinal lipoproteins. J. Clin. Invest. 1990, 85:883-892.
62. Krauss R.M., Levy R.I., Fredrickson D.S. Selective measurement of two lipase activities in postheparin plasma from normal subjects and patients with hyperlipoproteinemia. J. Clin. Invest. 1974, 54:1107-1124.
63. Kreisberg R.A., Kasim S. Cholesterol metabolism and aging. Am. J. Med. 1987, 82:54-60.
64. Kujala U.M., Alen M., Huhtaniemi I.T. Gonadotrophin-releasing hormone and human chorionic gonadotrophin tests reveal that both hypothalamic and testicular endocrine functions are suppressed during acute prolonged physical exercise. Clin. Endocrinol. (Oxf.) 1990, 33:219-225.
65. Kupfer R.M., Heppell M., Haggith J.W., Bateman D.N. Gastric emptying and small-bowel transit rate in the elderly. J. Am. Geriatr. Soc. 1985, 33:340-343.
66. Langer C., Gansz B., Goepfert C., Engel T., Uehara Y., von Dehn G., Jansen H., Assmann G., von Eckardstein A. Testosterone up-regulates scavenger receptor BI and stimulates cholesterol efflux from macrophages. Biochem. Biophys. Res. Commun. 2002, 296:1051-1057.
67. Le Couteur D.G., McLean A.J. The aging liver. Drug clearance and an oxygen diffusion barrier hypothesis. Clin. Pharmacokinet. 1998, 34:359-373.
68. Le Couteur D.G., Cogger V.C., Markus A.M., Harvey P.J., Yin Z.L., Ansselin A.D., McLean A.J. Pseudocapillarization and associated energy limitation in the aged rat liver. Hepatology 2001, 33:537-543.
69. Le Couteur D.G., Fraser R., Cogger V.C., McLean A.J. Hepatic pseudocapillarisation and atherosclerosis in ageing. Lancet 2002, 359:1612-1615.
70. Le Couteur D.G., Cogger V.C., McCuskey R.S., De Cabo R., Smedsrod B., Sorensen K.K., Warren A., Fraser R. Age-related changes in the liver sinusoidal endothelium: a mechanism for dyslipidemia. Ann. N. Y. Acad. Sci. 2007, 1114:79-87.
71. Lemieux I., Pascot A., Tchernof A., Bergeron J., Prud'homme D., Bouchard C., Despres J.P. Visceral adipose tissue and low-density lipoprotein particle size in middle-aged versus young men. Metabolism 1999, 48:1322-1327.
72. Leonsson M., Oscarsson J., Bosaeus I., Lundgren B.K., Johannsson G., Wiklund O., Bengtsson B.A. Growth hormone (GH) therapy in GH-deficient adults influences the response to a dietary load of cholesterol and saturated fat in terms of cholesterol synthesis, but not serum low density lipoprotein cholesterol levels. J. Clin. Endocrinol. Metab. 1999, 84:1296-1303.
73. Lerchbaum E., Pilz S., Boehm B.O., Grammer T.B., Obermayer-Pietsch B., Marz W. Combination of low free testosterone and low vitamin D predicts mortality in older men referred for coronary angiography. Clin. Endocrinol. (Oxf.) 2012, 77:475-483.
74. Li Y., Sugiyama E., Yokoyama S., Jiang L., Tanaka N., Aoyama T. Molecular mechanism of age-specific hepatic lipid accumulation in PPARalpha (+/-):LDLR (+/-) mice, an obese mouse model. Lipids 2008, 43:301-312.
75. Mahley R.W., Innerarity T.L. Lipoprotein receptors and cholesterol homeostasis. Biochim. Biophys. Acta 1983, 737:197-222.
76. Manolakou P., Angelopoulou R., Bakoyiannis C., Bastounis E. The effects of endogenous and exogenous androgens on cardiovascular disease risk factors and progression. Reprod. Biol. Endocrinol. 2009, 7:44.
77. McLean A.J., Le Couteur D.G. Aging biology and geriatric clinical pharmacology. Pharmacol. Rev. 2004, 56:163-184.
78. McLean A.J., Cogger V.C., Chong G.C., Warren A., Markus A.M., Dahlstrom J.E., Le Couteur D.G. Age-related pseudocapillarization of the human liver. J. Pathol. 2003, 200:112-117.
79. Millar J.S., Packard C.J. Heterogeneity of apolipoprotein B-100-containing lipoproteins: what we have learnt from kinetic studies. Curr. Opin. Lipidol. 1998, 9:197-202.
80. Millar J.S., Lichtenstein A.H., Cuchel M., Dolnikowski G.G., Hachey D.L., Cohn J.S., Schaefer E.J. Impact of age on the metabolism of VLDL, IDL, and LDL apolipoprotein B-100 in men. J. Lipid Res. 1995, 36:1155-1167.
81. Morley J.E., Kaiser F.E., Perry H.M., Patrick P., Morley P.M., Stauber P.M., Vellas B., Baumgartner R.N., Garry P.J. Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men. Metabolism 1997, 46:410-413.
82. Morris P.D., Channer K.S. Testosterone and cardiovascular disease in men. Asian J. Androl. 2012, 14:428-435.
83. Motojima K., Passilly P., Peters J.M., Gonzalez F.J., Latruffe N. Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor alpha and gamma activators in a tissue- and inducer-specific manner. J. Biol. Chem. 1998, 273:16710-16714.
84. Muller M., den Tonkelaar I., Thijssen J.H., Grobbee D.E., van der Schouw Y.T. Endogenous sex hormones in men aged 40-80 years. Eur. J. Endocrinol. 2003, 149:583-589.
85. Nakagawa A., Nagaosa K., Hirose T., Tsuda K., Hasegawa K., Shiratsuchi A., Nakanishi Y. Expression and function of class B scavenger receptor type I on both apical and basolateral sides of the plasma membrane of polarized testicular Sertoli cells of the rat. Dev. Growth Differ. 2004, 46:283-298.
86. Nathan L., Shi W., Dinh H., Mukherjee T.K., Wang X., Lusis A.J., Chaudhuri G. Testosterone inhibits early atherogenesis by conversion to estradiol: critical role of aromatase. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:3589-3593.
87. Neaves W.B., Johnson L., Porter J.C., Parker C.R., Petty C.S. Leydig cell numbers, daily sperm production, and serum gonadotropin levels in aging men. J. Clin. Endocrinol. Metab. 1984, 59:756-763.
88. Nestel P.J. Relationship between plasma triglycerides and removal of chylomicrons. J. Clin. Invest. 1964, 43:943-949.
89. Neve B.P., Fruchart J.C., Staels B. Role of the peroxisome proliferator-activated receptors (PPAR) in atherosclerosis. Biochem. Pharmacol. 2000, 60:1245-1250.
90. Newschaffer C.J., Bush T.L., Hale W.E. Aging and total cholesterol levels: cohort, period, and survivorship effects. Am. J. Epidemiol. 1992, 136:23-34.
91. Nilsson P.M., Moller L., Solstad K. Adverse effects of psychosocial stress on gonadal function and insulin levels in middle-aged males. J. Intern. Med. 1995, 237:479-486.
92. Niu Z., Lin N., Gu R., Sun Y., Feng Y. Associations between insulin resistance, free fatty acids, and oocyte quality in polycystic ovary syndrome during in vitro fertilization. J. Clin. Endocrinol. Metab. 2014, 99:2269-2276.
93. Parini P., Angelin B., Lobie P.E., Norstedt G., Rudling M. Growth hormone specifically stimulates the expression of low density lipoprotein receptors in human hepatoma cells. Endocrinology 1995, 136:3767-3773.
94. Parini P., Angelin B., Rudling M. Cholesterol and lipoprotein metabolism in aging: reversal of hypercholesterolemia by growth hormone treatment in old rats. Arterioscler. Thromb. Vasc. Biol. 1999, 19:832-839.
95. Perdomo G., Henry Dong H. Apolipoprotein D in lipid metabolism and its functional implication in atherosclerosis and aging. Aging (Milano) 2009, 1:17-27.
96. Peters J.M., Hennuyer N., Staels B., Fruchart J.C., Fievet C., Gonzalez F.J., Auwerx J. Alterations in lipoprotein metabolism in peroxisome proliferator-activated receptor alpha-deficient mice. J. Biol. Chem. 1997, 272:27307-27312.
97. Phillips G.B., Pinkernell B.H., Jing T.Y. The association of hypotestosteronemia with coronary artery disease in men. Arterioscler. Thromb. 1994, 14:701-706.
98. Plutzky J. Emerging concepts in metabolic abnormalities associated with coronary artery disease. Curr. Opin. Cardiol. 2000, 15:416-421.
99. Poehlman E.T., Toth M.J., Bunyard L.B., Gardner A.W., Donaldson K.E., Colman E., Fonong T., Ades P.A. Physiological predictors of increasing total and central adiposity in aging men and women. Arch. Intern. Med. 1995, 155:2443-2448.
100. Pohlel K., Grow P., Helmy T., Wenger N.K. Treating dyslipidemia in the elderly. Curr. Opin. Lipidol. 2006, 17:54-57.
101. Pontiroli A.E., Manzoni M.F., Malighetti M.E., Lanzi R. Restoration of growth hormone (GH) response to GH-releasing hormone in elderly and obese subjects by acute pharmacological reduction of plasma free fatty acids. J. Clin. Endocrinol. Metab. 1996, 81:3998-4001.
102. Reaven G.M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988, 37:1595-1607.
103. Rubens R., Dhont M., Vermeulen A. Further studies on Leydig cell function in old age. J. Clin. Endocrinol. Metab. 1974, 39:40-45.
104. Rudling M., Parini P., Angelin B. Growth hormone and bile acid synthesis. Key role for the activity of hepatic microsomal cholesterol 7alpha-hydroxylase in the rat. J. Clin. Invest. 1997, 99:2239-2245.
105. Sanguino E., Roglans N., Alegret M., Sanchez R.M., Vazquez-Carrera M., Laguna J.C. Atorvastatin reverses age-related reduction in rat hepatic PPARalpha and HNF-4. Br. J. Pharmacol. 2005, 145:853-861.
106. Schaefer E.J., Moussa P.B., Wilson P.W., McGee D., Dallal G., Castelli W.P. Plasma lipoproteins in healthy octogenarians: lack of reduced high density lipoprotein cholesterol levels: results from the Framingham Heart Study. Metabolism 1989, 38:293-296.
107. Schleich F., Legros J.J. Effects of androgen substitution on lipid profile in the adult and aging hypogonadal male. Eur. J. Endocrinol. 2004, 151:415-424.
108. Seternes T., Sorensen K., Smedsrod B. Scavenger endothelial cells of vertebrates: a nonperipheral leukocyte system for high-capacity elimination of waste macromolecules. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:7594-7597.
109. Shanmugasundaram M., Rough S.J., Alpert J.S. Dyslipidemia in the elderly: should it be treated?. Clin. Cardiol. 2010, 33:4-9.
110. Sial S., Coggan A.R., Carroll R., Goodwin J., Klein S. Fat and carbohydrate metabolism during exercise in elderly and young subjects. Am. J. Physiol. 1996, 271:E983-E989.
111. Sjoberg A., Oscarsson J., Bostrom K., Innerarity T.L., Eden S., Olofsson S.O. Effects of growth hormone on apolipoprotein-B (apoB) messenger ribonucleic acid editing, and apoB 48 and apoB 100 synthesis and secretion in the rat liver. Endocrinology 1992, 130:3356-3364.
112. Sjoberg A., Oscarsson J., Eden S., Olofsson S.O. Continuous but not intermittent administration of growth hormone to hypophysectomized rats increases apolipoprotein-E secretion from cultured hepatocytes. Endocrinology 1994, 134:790-798.
113. Slowinska-Srzednicka J., Zgliczynski S., Ciswicka-Sznajderman M., Srzednicki M., Soszynski P., Biernacka M., Woroszylska M., Ruzyllo W., Sadowski Z. Decreased plasma dehydroepiandrosterone sulfate and dihydrotestosterone concentrations in young men after myocardial infarction. Atherosclerosis 1989, 79:197-203.
114. Sonntag W.E., Steger R.W., Forman L.J., Meites J. Decreased pulsatile release of growth hormone in old male rats. Endocrinology 1980, 107:1875-1879.
115. Stahlberg D., Angelin B., Einarsson K. Age-related changes in the metabolism of cholesterol in rat liver microsomes. Lipids 1991, 26:349-352.
116. Sung B., Park S., Yu B.P., Chung H.Y. Modulation of PPAR in aging, inflammation, and calorie restriction. J. Gerontol. A Biol. Sci. Med. Sci. 2004, 59:997-1006.
117. Sutherland J.P., McKinley B., Eckel R.H. The metabolic syndrome and inflammation. Metab. Syndr. Relat. Disord. 2004, 2:82-104.
118. Tessari P. Changes in protein, carbohydrate, and fat metabolism with aging: possible role of insulin. Nutr. Rev. 2000, 58:11-19.
119. Toth M.J., Tchernof A. Lipid metabolism in the elderly. Eur. J. Clin. Nutr. 2000, 54(Suppl. 3):S121-S125.
120. Turakhia M., Tseng Z.H. Sudden cardiac death: epidemiology, mechanisms, and therapy. Curr. Probl. Cardiol. 2007, 32:501-546.
121. Van Pottelbergh I., Braeckman L., De Bacquer D., De Backer G., Kaufman J.M. Differential contribution of testosterone and estradiol in the determination of cholesterol and lipoprotein profile in healthy middle-aged men. Atherosclerosis 2003, 166:95-102.
122. Vermeulen A., Rubens R., Verdonck L. Testosterone secretion and metabolism in male senescence. J. Clin. Endocrinol. Metab. 1972, 34:730-735.
123. von Eckardstein A., Nofer J.R., Assmann G. High density lipoproteins and arteriosclerosis. Role of cholesterol efflux and reverse cholesterol transport. Arterioscler. Thromb. Vasc. Biol. 2001, 21:13-27.
124. Vu-Dac N., Schoonjans K., Laine B., Fruchart J.C., Auwerx J., Staels B. Negative regulation of the human apolipoprotein A-I promoter by fibrates can be attenuated by the interaction of the peroxisome proliferator-activated receptor with its response element. J. Biol. Chem. 1994, 269:31012-31018.
125. Vu-Dac N., Schoonjans K., Kosykh V., Dallongeville J., Fruchart J.C., Staels B., Auwerx J. Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor. J. Clin. Invest. 1995, 96:741-750.
126. Walter M. Interrelationships among HDL metabolism, aging, and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2009, 29:1244-1250.
127. Warren A., Bertolino P., Cogger V.C., McLean A.J., Fraser R., Le Couteur D.G. Hepatic pseudocapillarization in aged mice. Exp. Gerontol. 2005, 40:807-812.
128. Wegener M., Borsch G., Schaffstein J., Luth I., Rickels R., Ricken D. Effect of ageing on the gastro-intestinal transit of a lactulose-supplemented mixed solid-liquid meal in humans. Digestion 1988, 39:40-46.
129. Weintraub M.S., Eisenberg S., Breslow J.L. Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E. J. Clin. Invest. 1987, 80:1571-1577.
130. Wickramatilake C.M., Mohideen M.R., Pathirana C. Association of serum testosterone with lipid abnormalities in patients with angiographically proven coronary artery disease. Ind. J. Endocrinol. Metab. 2013, 17:1061-1065.
131. Wu F.C., von Eckardstein A. Androgens and coronary artery disease. Endocr. Rev. 2003, 24:183-217.
132. Ye P., Wang Z.J., Zhang X.J., Zhao Y.L. Age-related decrease in expression of peroxisome proliferator-activated receptor alpha and its effects on development of dyslipidemia. Chin. Med. J. (Engl.) 2005, 118:1093-1098.
133. Yeap B.B. Androgens and cardiovascular disease. Curr. Opin. Endocrinol. Diabetes Obes. 2010, 17:269-276.
134. Zhao S.P., Li X.P. The association of low plasma testosterone level with coronary artery disease in Chinese men. Int. J. Cardiol. 1998, 63:161-164.
135. Zmuda J.M., Cauley J.A., Kriska A., Glynn N.W., Gutai J.P., Kuller L.H. Longitudinal relation between endogenous testosterone and cardiovascular disease risk factors in middle-aged men. A 13-year follow-up of former multiple risk factor intervention trial participants. Am. J. Epidemiol. 1997, 146:609-617.
136. Zumoff B., Strain G.W., Miller L.K., Rosner W., Senie R., Seres D.S., Rosenfeld R.S. Plasma free and non-sex-hormone-binding-globulin-bound testosterone are decreased in obese men in proportion to their degree of obesity. J. Clin. Endocrinol. Metab. 1990, 71:929-931.